Evidence map›Paper›PMID 31993374›Full record

ReviewFrontiers in cellular and infection microbiology2019

How to B(e)-1 Important Cell During

Luan Firmino-Cruz, Debora Decote-Ricardo, Daniel Claudio de Oliveira Gomes, Alexandre Morrot, Celio Geraldo Freire-de-Lima, Herbert Leonel de Matos Guedes

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A difficult to treatIDCases · 2023
    Article
  5. Review
  6. Humoral response in Leishmaniasis.Frontiers in cellular and infection microbiology · 2022
    Review
  7. Article
  8. Modulation of Host Immune Response duringFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Luan Firmino-CruzLaboratório de Imunofarmacologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Debora Decote-RicardoInstituto de Veterinária, Universidade Federal Rural Do Rio de Janeiro, Seropédica, Brazil.
Daniel Claudio de Oliveira GomesNúcleo de Doenças Infecciosas/Núcleo de Biotecnologia, Universidade Federal Do Espírito Santo, Vitoria, Brazil.
Alexandre MorrotLaboratório de Imunopatologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Celio Geraldo Freire-de-LimaLaboratório de Imunomodulação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Herbert Leonel de Matos GuedesLaboratório de Imunofarmacologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRUniversidade Federal do Espírito Santo · BRUniversidade Federal Rural do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-1 cells are an innate-like population of B lymphocytes that are subdivided into B-1a and B-1b distinguished by the presence or absence of CD5, respectively. B-1 cells can act as regulatory B cells, are able to present antigen and produce IL-10. Leishmaniasis in humans is a complex of diseases caused by parasites of the genus

Indexed as

Agammaglobulinaemia Tyrosine KinaseAnimalsB-LymphocytesB-Lymphocyte SubsetsCytokinesDisease Models, AnimalDisease ProgressionHumansInterleukin-10LeishmaniaLeishmania infantumLeishmania majorLeishmaniasisMiceMice, Inbred BALB CMice, Inbred C57BLAgammaglobulinaemia Tyrosine KinaseCytokinesIL10 protein, mouseInterleukin-10B-1CDP cellsB-1 cellsBALB/XIDIL-10Leishmaniasis

Identifiers

PMID31993374
PMCPMC6970944
OpenAlexW2992415096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.